![Stephen N. Kirnon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen N. Kirnon
Vorstandsvorsitzender bei
PharmaPlan LLC
Profil
Stephen N.
Kirnon is the founder of PharmaPlan LLC, which was founded in 2009.
He is currently the Chief Executive Officer at Vitavis Laboratories, Inc. and a Trustee at The New England College of Optometry.
Dr. Kirnon's former positions include President & Chief Executive Officer at Pepgen Corp.
and Target Protein Technologies, Inc., Independent Director at Soleno Therapeutics, Inc. from 2002 to 2017, Chief Operating Officer & Director at Yamanouchi Pharma Technologies, Inc., President-Drug Delivery Division at Cygnus, Inc., and Principal at Smithkline Beecham Plc and BioGenex Laboratories, Inc. Dr. Kirnon received his undergraduate degree from Harvard University and his MBA and doctorate degrees from Pepperdine University.
Aktive Positionen von Stephen N. Kirnon
| Unternehmen | Position | Beginn |
|---|---|---|
PharmaPlan LLC | Vorstandsvorsitzender | 01.01.2009 |
The New England College of Optometry
 The New England College of Optometry Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | - |
Vitavis Laboratories, Inc.
 Vitavis Laboratories, Inc. Medical/Nursing ServicesHealth Services Develops products to optimize the human metabolism | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Stephen N. Kirnon
| Unternehmen | Position | Ende |
|---|---|---|
| SOLENO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 31.12.2017 |
Yamanouchi Pharma Technologies, Inc. | Geschäftsführer | - |
Target Protein Technologies, Inc. | Vorstandsvorsitzender | - |
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | - |
BioGenex Laboratories, Inc.
 BioGenex Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Provides solutions for automation of cell and tissue testing | Corporate Officer/Principal | - |
Ausbildung von Stephen N. Kirnon
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
26
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Cygnus, Inc.
 Cygnus, Inc. Medical SpecialtiesHealth Technology Develops and manufactures glucose-monitoring devices | Health Technology |
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Pepgen Corp.
 Pepgen Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes products for the prevention, treatment of autoimmune and viral disorders | Health Technology |
Soleno Therapeutics, Inc.
 Soleno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes novel therapeutics for the treatment of rare diseases | Health Technology |
Vitavis Laboratories, Inc.
Vitavis Laboratories, Inc. Medical/Nursing ServicesHealth Services Develops products to optimize the human metabolism | Health Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pepperdine University
 Pepperdine University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioGenex Laboratories, Inc.
BioGenex Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Provides solutions for automation of cell and tissue testing | Health Technology |
The New England College of Optometry
The New England College of Optometry Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PharmaPlan LLC | |
Target Protein Technologies, Inc. | |
Yamanouchi Pharma Technologies, Inc. |
